Risk.net

Interest Rates House of the Year

Interest Rates House of the Year

amit-agarwal-barcap
Amit Agarwal, Barclays Capital
    • Richard Jory
  • LinkedIn  
  • Save this article
  • Print this page  

Barclays Capital

Producing hybrids on a vast scale has been at the heart of Barclays Capital's success in Asia. The bank has also rolled out an impressive set of beta and portable alpha strategies to an Asian market that is developing and only expects to get bigger.

Low interest rates have been the spur for the BarCap to expand its range and influence in the world of rates hybrids, as investors continue their hunt for yield and yield enhancement. Calling its solutions "elegant", the bank has

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.

More on Awards

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here